Literature DB >> 27880900

Tailored Tumor Immunogenicity Reveals Regulation of CD4 and CD8 T Cell Responses against Cancer.

Sarah Knocke1, Bettina Fleischmann-Mundt1, Michael Saborowski1, Michael P Manns1, Florian Kühnel1, Thomas C Wirth1, Norman Woller2.   

Abstract

CD4 and CD8 T cells play a pivotal role in controlling tumor growth. However, the interplay of both cell types and their role in tumor suppression still remain elusive. In this study, we investigated the regulation of CD4 and CD8 T cell responses to different classes of tumor-specific antigens in liver cancer mouse models. Tumors were induced in p19Arf-deficient mice by hydrodynamic injection of transposon plasmids encoding NrasG12V and pre-defined tumor antigens. This allowed for assessing the regulation of tumor-specific CD4 and CD8 T cell responses. We showed that MHC class I tumor immunogenicity was essential to trigger tumor-directed CD4 T cells. Tumor-specific CD8 T cell responses arose independently of CD4 T cells, but they required Th1-polarized CD4 T cells for efficient tumor suppression. Our results further indicate that the immune system is incapable of eliciting sufficient numbers of T cells directed against antigens derived from immunoedited tumors, which consequently leads to a lack of T-cell-mediated tumor suppression in untreated hosts. Copyright Â
© 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD4 T cells; CD8 T cells; T cell regulation; cancer immunosurveillance; cancer mouse model; immune responses to cancer; immunoediting; neoepitopes; oncogenic ras; senescence surveillance

Mesh:

Substances:

Year:  2016        PMID: 27880900     DOI: 10.1016/j.celrep.2016.10.086

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  21 in total

Review 1.  The opposing roles of CD4+ T cells in anti-tumour immunity.

Authors:  Tomasz Ahrends; Jannie Borst
Journal:  Immunology       Date:  2018-04-27       Impact factor: 7.397

Review 2.  CD4 and CD8 T lymphocyte interplay in controlling tumor growth.

Authors:  Dmitrij Ostroumov; Nora Fekete-Drimusz; Michael Saborowski; Florian Kühnel; Norman Woller
Journal:  Cell Mol Life Sci       Date:  2017-10-14       Impact factor: 9.261

Review 3.  The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.

Authors:  Emma J de Ruiter; Marc L Ooft; Lot A Devriese; Stefan M Willems
Journal:  Oncoimmunology       Date:  2017-08-09       Impact factor: 8.110

Review 4.  Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?

Authors:  Thomas C Wirth; Florian Kühnel
Journal:  Front Immunol       Date:  2017-12-19       Impact factor: 7.561

5.  Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progression.

Authors:  Ying-Yi Wang; Na Zhou; Hong-Sheng Liu; Xiao-Lei Gong; Rui Zhu; Xiao-Yuan Li; Zhao Sun; Xu-Hong Zong; Ning-Ning Li; Chang-Ting Meng; Chun-Mei Bai; Tai-Sheng Li
Journal:  Cancer Med       Date:  2020-05-27       Impact factor: 4.452

6.  Myeloid-derived suppressor cells infiltration in non-small-cell lung cancer tumor and MAGE-A4 and NY-ESO-1 expression.

Authors:  Zhenbo Hou; Xiao Liang; Xinmei Wang; Ziqiang Zhou; Guilan Shi
Journal:  Oncol Lett       Date:  2020-03-31       Impact factor: 2.967

7.  Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads.

Authors:  Danielle M Lussier; Elise Alspach; Jeffrey P Ward; Alexander P Miceli; Daniele Runci; J Michael White; Cedric Mpoy; Cora D Arthur; Heather N Kohlmiller; Tyler Jacks; Maxim N Artyomov; Buck E Rogers; Robert D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

8.  A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma.

Authors:  Sujun Sun; Haiyu Ji; Yingying Feng; Yu Kang; Juan Yu; Anjun Liu
Journal:  Cancer Manag Res       Date:  2018-03-05       Impact factor: 3.989

9.  Prognostic value of neutrophil-to-lymphocyte ratio in peripheral blood and pathological tissue in patients with esophageal squamous cell carcinoma.

Authors:  Quanquan Guo; Zhiying Shao; Dan Xu; Lili Fan; Huiru Xiong; Xin Ding; Chuanwen You; Longzhen Zhang
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

10.  Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses.

Authors:  Erkko Ylösmäki; Cristina Malorzo; Cristian Capasso; Oona Honkasalo; Manlio Fusciello; Beatriz Martins; Leena Ylösmäki; Antti Louna; Sara Feola; Henrik Paavilainen; Karita Peltonen; Veijo Hukkanen; Tapani Viitala; Vincenzo Cerullo
Journal:  Mol Ther       Date:  2018-06-19       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.